Go to Repurposing potential drug candidates for the treatment of COVID-19
Repurposing potential drug candidates for the treatment of COVID-19
Summary The main protease (Mpro) in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for the coronavirus disease (COVID-19), has emerged as a promising drug target. The scientific community has produced a large number of crystallographic structures of the protease, which mediates viral replication and transcription. These structures report several fragments with varied chemotypes […]
May 6, 2020
